Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director · 10% owner | March 21, 2025 | March 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date March 21, 2025 · Filed March 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-03-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-21 · Conversion · Acquired 7,000,000 · Balance 7,000,000 F1: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis. F2: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Row 2 · 2025-03-21 · Disposition to issuer · Disposed 7,000,000 · Balance 0 F1: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 43,164,171 |
Reported balance
After 2025-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-21 · Conversion · Disposed 7,000,000 · Balance 43,164,171 F2: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis.
F2: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 27, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 75,488 | $43.35 | $3,272,072.65 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.18 to $43.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 215,756 | $42.83 | $9,239,837.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,488 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.18 to $43.17 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 291,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 70,201 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · derivative · entry 9 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,835,217 Underlying: Class A Common Stock · 70,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F7 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F7 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 990 | $33.63 | $33,289.15 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.54 to $33.69, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 63,261 | $33.13 | $2,095,691.43 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.54 to $33.53, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 5,950 | $31.79 | $189,169.54 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,251 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.44 to $32.41, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 70,201 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 337,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · derivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,905,414 Underlying: Class A Common Stock · 337,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F7 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F7 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 3,100 | $33.00 | $102,306.20 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.09 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 334,186 | $32.13 | $10,736,727.81 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.88 to $32.84 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 16:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 337,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-028003 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 398,515 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · derivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,242,704 Underlying: Class A Common Stock · 398,515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 13,274 | $33.29 | $441,924.65 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.55, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 385,241 | $32.76 | $12,618,723.05 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,274 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 398,515 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 135,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · derivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,641,219 Underlying: Class A Common Stock · 135,732 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 700 | $34.77 | $24,339.00 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 135,032 | $34.03 | $4,595,368.51 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.71 to $34.60 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 18:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 135,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027821 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 249,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · derivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,776,951 Underlying: Class A Common Stock · 249,367 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 52,827 | $35.68 | $1,884,962.45 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.23 to $36.16, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 196,540 | $34.67 | $6,813,157.37 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,827 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $35.17, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 249,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 275,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · derivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,026,318 Underlying: Class A Common Stock · 275,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 22,644 | $36.41 | $824,415.96 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.37 to $36.46 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 252,768 | $35.92 | $9,080,336.52 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,644 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.37 to $36.36 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 18:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 275,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027314 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 213,351 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · derivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,301,730 Underlying: Class A Common Stock · 213,351 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 11,081 | $36.87 | $408,534.31 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.79 to $36.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 202,270 | $36.18 | $7,317,622.93 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.79 to $38.785 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 213,351 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 124,973 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · derivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,555,515,081 Underlying: Class A Common Stock · 124,973 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 124,973 | $37.39 | $4,672,490.52 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.02 to $37.96 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 16:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 124,973 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026753 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 260,241 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · derivative · entry 9 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,640,054 Underlying: Class A Common Stock · 260,241 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 6,781 | $38.88 | $263,662.23 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 72,739 | $37.95 | $2,760,110.45 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,781 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.73 to $38.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 180,721 | $37.14 | $6,712,321.31 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,520 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.73 to $37.72 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 260,241 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 163,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · derivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,900,295 Underlying: Class A Common Stock · 163,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F6 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 562 | $39.03 | $21,934.86 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 163,009 | $38.52 | $6,278,699.16 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.03 to $38.99 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 163,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-026255 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 19:04 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 106,015 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013967 · doc4.xml · derivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,063,866 Underlying: Class A Common Stock · 106,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 19:04 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 72,160 | $37.86 | $2,731,999.25 |
DisclosureSEC source: 0000899243-21-013967 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $38.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 19:04 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 33,855 | $37.10 | $1,255,851.23 |
DisclosureSEC source: 0000899243-21-013967 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,160 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.49 to $37.48 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 19:04 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 106,015 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013967 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 1,192,022 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013565 · doc4.xml · derivative · entry 16 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,169,881 Underlying: Class A Common Stock · 1,192,022 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F11 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F11 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 1,216 | $37.69 | $45,836.15 |
DisclosureSEC source: 0000899243-21-013565 · doc4.xml · nonDerivative · entry 13 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.69 to $37.95, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.